EV/EBITDA
-117.59
+0.02+0.02%
7 min ago
Summary
- As of March 12, 2025, ITCI EV/EBITDA is -117.59, with a rise of +0.02 (+0.02%) during the most recent trading day.
- Over the past year, ITCI EV/EBITDA has dropped by -79.53 (-208.96%).
- ITCI EV/EBITDA is now -5553.37% below its all-time high of -2.08.
Performance
ITCI EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
ITCI EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | +0.0% | -0.0% | -0.0% |
| 1 m1 month | -3.1% | +3.1% | +3.0% |
| 3 m3 months | -62.6% | +62.6% | +60.0% |
| 6 m6 months | -81.0% | +87.9% | +74.5% |
| ytdytd | -59.3% | +59.3% | +57.2% |
| 1 y1 year | -209.0% | +126.0% | +105.7% |
| 5 y5 years | -1751.8% | +1301.7% | +719.3% |
ITCI EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -3.4% | -117.68 | +0.1% | |
| 3 m | 3-month | -72.02 | -63.3% | -117.68 | +0.1% |
| 6 m | 6-month | -58.33 | -101.6% | -117.68 | +0.1% |
| 1 y | 1-year | -28.43 | -313.6% | -117.68 | +0.1% |
| 3 y | 3-year | -12.86 | -814.4% | -117.68 | +0.1% |
| 5 y | 5-year | -4.75 | -2375.6% | -117.68 | +0.1% |
| alltime | all time | -2.08 | -5553.4% | -117.68 | +0.1% |
Intra-Cellular Therapies EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -117.59(+59.3%) |
| 2024 | -73.82(+72.2%) |
| 2023 | -42.86(+130.6%) |
| 2022 | -18.59(+25.6%) |
| 2021 | -14.80(+35.0%) |
| 2020 | -10.96(-7.5%) |
| Date | Value |
|---|---|
| 2019 | -11.85(+236.6%) |
| 2018 | -3.52(-52.1%) |
| 2017 | -7.35(+41.6%) |
| 2016 | -5.19(-76.0%) |
| 2015 | -21.67(+44.7%) |
| 2014 | -14.98 |
FAQ
- What is Intra-Cellular Therapies EV/EBITDA?
- What is the all time high EV/EBITDA for Intra-Cellular Therapies?
- What is ITCI EV/EBITDA year-to-date change?
- What is Intra-Cellular Therapies EV/EBITDA year-on-year change?
What is Intra-Cellular Therapies EV/EBITDA?
The current EV/EBITDA of ITCI is -117.59
What is the all time high EV/EBITDA for Intra-Cellular Therapies?
Intra-Cellular Therapies all-time high EV/EBITDA is -2.08
What is ITCI EV/EBITDA year-to-date change?
Intra-Cellular Therapies EV/EBITDA has changed by -43.77 (-59.29%) since the beginning of the year
What is Intra-Cellular Therapies EV/EBITDA year-on-year change?
Over the past year, ITCI EV/EBITDA has changed by -79.53 (-208.96%)